Cargando…

No evidence of firstly acquired acute hepatitis C virus infection outbreak among HIV-infected patients from Southern Spain: a multicentric retrospective study from 2000-2014

BACKGROUND: Acute hepatitis C virus (HCV) infection (AHCVI) outbreaks have been described recently within defined areas worldwide among HIV-infected homosexual men. This study aims to describe the cumulative frequency and incidence of firstly acquired AHCVI in an HIV-infected population in Southern...

Descripción completa

Detalles Bibliográficos
Autores principales:	Neukam, Karin, Viciana, Pompeyo, Ojeda-Burgos, Guillermo, Delgado-Fernández, Marcial, Ríos, María J., Macías, Juan, Merino, Dolores, Collado, Antonio, Téllez, Francisco, Pineda, Juan A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5025585/ https://www.ncbi.nlm.nih.gov/pubmed/27634297 http://dx.doi.org/10.1186/s12879-016-1826-2

Ejemplares similares

High-resolution anoscopy in HIV-infected men: Assessment of the learning curve and factors that improve the performance
por: Neukam, Karin, et al.
Publicado: (2019)

Hepatic Safety of Rilpivirine/Emtricitabine/Tenofovir Disoproxil Fumarate Fixed-Dose Single-Tablet Regimen in HIV-Infected Patients with Active Hepatitis C Virus Infection: The hEPAtic Study
por: Neukam, Karin, et al.
Publicado: (2016)

Sexually Transmitted Infections and Associated Factors in Southeast Spain: A Retrospective Study from 2000 to 2014
por: Pérez-Morente, María Ángeles, et al.
Publicado: (2020)

Liver Toxicity of Current Antiretroviral Regimens in HIV-Infected Patients with Chronic Viral Hepatitis in a Real-Life Setting: The HEPAVIR SEG-HEP Cohort
por: Neukam, Karin, et al.
Publicado: (2016)

Low Efficacy of Pegylated Interferon plus Ribavirin plus Nitazoxanide for HCV Genotype 4 and HIV Coinfection
por: Macías, Juan, et al.
Publicado: (2015)

Dimension of chronic hepatitis C virus in HIV-infected patients in the interferon-free era: an overview from south Spain
por: Rivero-Juarez, A., et al.
Publicado: (2015)

Hepatic safety of RPV/FTC/TDF single tablet regimen in HIV/HCV-coinfected patients. Preliminary results of the hEPAtic Study
por: Neukam, Karin, et al.
Publicado: (2014)

Efficacy, safety and pharmacokinetic of once-daily boosted saquinavir (1500/100 mg) together with 2 nucleos(t)ide reverse transcriptase inhibitors in real life: a multicentre prospective study
por: López-Cortés, Luis F, et al.
Publicado: (2010)

What is needed to achieve HCV microelimination among HIV-infected populations in Andalusia, Spain: a modeling analysis
por: Skaathun, Britt, et al.
Publicado: (2020)

Prevalence and resistance mutations of non-B HIV-1 subtypes among immigrants in Southern Spain along the decade 2000-2010
por: de Felipe, Beatriz, et al.
Publicado: (2011)

Baseline resistance-guided therapy does not enhance the response to interferon-free treatment of HCV infection in real life
por: Real, Luis M., et al.
Publicado: (2018)

Eligibility for and outcome of treatment of latent tuberculosis infection in a cohort of HIV-infected people in Spain
por: Diaz, Asuncion, et al.
Publicado: (2010)

Impact of lopinavir-ritonavir exposure in HIV-1 infected children and adolescents in Madrid, Spain during 2000-2014
por: Rojas Sánchez, Patricia, et al.
Publicado: (2017)

Differences in Sexually Transmitted Infections between the Precrisis Period (2000–2007) and the Crisis Period (2008–2014) in Granada, Spain
por: Pérez-Morente, María Ángeles, et al.
Publicado: (2019)

Monotherapy with darunavir/ritonavir is effective and safe in clinical practice
por: Pasquau, Juan, et al.
Publicado: (2014)

Chikungunya virus infections among travellers returning to Spain, 2008 to 2014
por: Fernandez-Garcia, Maria Dolores, et al.
Publicado: (2016)

Prevalence of hepatitis E infection in HIV/HCV-coinfected patients in Spain (2012–2014)
por: Vázquez-Morón, Sonia, et al.
Publicado: (2019)

No difference in effectiveness of treatment simplification to boosted or unboosted atazanavir plus lamivudine in virologically suppressed in HIV-1-infected patients
por: Gutierrez-Valencia, Alicia, et al.
Publicado: (2018)

Trends in urinary tract infection hospitalization in older adults in Spain from 2000-2015
por: Redondo-Sánchez, Jesús, et al.
Publicado: (2021)

HCV Viral Decline at Week 2 of Peg-IFN-Alpha-2a/RBV Therapy as a Predictive Tool for Tailoring Treatment in HIV/HCV Genotype 1 Co-Infected Patients
por: Rivero-Juarez, Antonio, et al.
Publicado: (2014)

Effectiveness of Ritonavir-Boosted Protease Inhibitor Monotherapy in Clinical Practice Even with Previous Virological Failures to Protease Inhibitor-Based Regimens
por: López-Cortés, Luis F., et al.
Publicado: (2016)

Autochthonous Nocardia cerradoensis Infection in Humans, Spain, 2011 and 2014
por: Ercibengoa, Maria, et al.
Publicado: (2016)

Pulmonary Infections with Nontuberculous Mycobacteria, Catalonia, Spain, 1994–2014
por: Santin, Miguel, et al.
Publicado: (2018)

Genetic markers of lipid metabolism genes associated with low susceptibility to HCV infection
por: Real, Luis Miguel, et al.
Publicado: (2019)

Clinical and Virological Efficacy of Etravirine Plus Two Active Nucleos(t)ide Analogs in an Heterogeneous HIV-Infected Population
por: López-Cortés, Luis F., et al.
Publicado: (2014)

Absolute CD4(+) T cell count overstate immune recovery assessed by CD4(+)/CD8(+) ratio in HIV-infected patients on treatment
por: Milanés-Guisado, Yusnelkis, et al.
Publicado: (2018)

Invasive Fusariosis in Nonneutropenic Patients, Spain, 2000–2015
por: Pérez-Nadales, Elena, et al.
Publicado: (2021)

Analysis of 415 adverse events in dental practice in Spain from 2000 to 2010
por: Perea-Pérez, Bernardo, et al.
Publicado: (2014)

Using machine learning methods to determine a typology of patients with HIV-HCV infection to be treated with antivirals
por: Rivero-Juárez, Antonio, et al.
Publicado: (2020)

Pregnancy outcomes in perinatally HIV-infected young women in Madrid, Spain: 2000-2015
por: Prieto, Luis M., et al.
Publicado: (2017)

Differential Effects of Viremia and Microbial Translocation on Immune Activation in HIV-Infected Patients Throughout Ritonavir-Boosted Darunavir Monotherapy
por: BenMarzouk-Hidalgo, Omar J., et al.
Publicado: (2015)

Hospitalizations realted to herpes zoster infection in the Canary Islands, Spain (2005-2014)
por: García-Rojas, Amós, et al.
Publicado: (2017)

Healthcare-associated infections by multidrug-resistant bacteria in Andalusia, Spain, 2014 to 2021
por: Fernández-Martínez, Nicolás Francisco, et al.
Publicado: (2023)

Incidence of and factors associated with SARS‐CoV‐2 infection among people living with HIV in Southern Spain after one year of pandemic
por: Fernandez‐Fuertes, Marta, et al.
Publicado: (2021)

IFNL4 ss469415590 Variant Shows Similar Performance to rs12979860 as Predictor of Response to Treatment against Hepatitis C Virus Genotype 1 or 4 in Caucasians
por: Real, Luis M., et al.
Publicado: (2014)

Hepatitis E 3ra Genotype Infection in People Living With HIV in Spain
por: Rivero-Juarez, Antonio, et al.
Publicado: (2020)

Birth defects in a cohort of infants born to HIV-infected women in Spain, 2000-2009
por: Prieto, Luis M, et al.
Publicado: (2014)

Cryptosporidium felis Infection, Spain
por: Llorente, María Teresa, et al.
Publicado: (2006)

Is temperature change a key driver of the regional differences in electricity consumption of the economic sectors in Spain (2000–2016)?
por: Román-Collado, Rocío, et al.
Publicado: (2023)

Prevalence of resistance associated substitutions and efficacy of baseline resistance-guided chronic hepatitis C treatment in Spain from the GEHEP-004 cohort
por: Pérez, Ana Belén, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jghsisj37v697e8mboq762ffis